Why Accuracy Matters in Digital Pathology Podcast with Keith Wharton, Jr., MD PhD, Global Medical Affairs Leader – Pathology – Roche
In this episode, Dr. Aleksandra Zuraw speaks with Dr. Keith Wharton, Global Medical Director at Roche Diagnostics, about the complex but fascinating journey toward FDA clearance for the Roche Digital…
Read the full articleYou might also wanna read
EMA advisor discusses real-world data and single-arm trials in oncology drug approvals
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in th
Griffin Budde։ New Data Continue to Support Signatera Use in Merkel Cell Carcinoma
Griffin Budde, Director of Oncology Sales – Cutaneous at Natera, shared a post on LinkedIn: “‘Conclusions and Relevance: This study found th
Leica Biosystems Launches AI-Powered Digital Pathology Solution in Europe, Middle East and Africa
High-throughput Aperio GT Elite scanner with AI-enabled quality control supports digital and computational pathology workflows
Stephen Liu: High Response Rates for Frontline Ifebemtinib/Garsorasib in KRAS G12C NSCLC
Stephen Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi
Versant Diagnostics Expands Collaboration with Leica Biosystems as PRW Laboratories Becomes First to Deploy Aperio GT Elite Solution
Milestone deployment reflects growing demand for high-throughput, AI-enabled digital pathology workflows
HealthLink on Air radio show: January 17, 2016
January 17, 2016 January 17, 2016 Stephen Graziano Stephen Graziano , MD, Upstate's division chief of hematology and oncology, shares what's

Comments
Sign in to join the conversation.
No comments yet. Be the first.